Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)
1 other identifier
interventional
28
1 country
1
Brief Summary
Use of on-line blood volume monitoring during continuous renal replacement therapy can improve volume management in acute kidney injury patients requiring renal replacement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 28, 2011
CompletedFirst Posted
Study publicly available on registry
July 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedAugust 8, 2012
August 1, 2012
2.3 years
July 28, 2011
August 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
compare number of hypotensive events in treatment versus control arms
compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period
24 hour for each arm
Study Arms (2)
Standard volume management
PLACEBO COMPARATORpatients on this arm will receive usual care volume management during continuous renal replacement therapy
continuous volume management
ACTIVE COMPARATORuse of Critline, Hemametrics USA, in conjunction with continuous renal replacment therapy to determine volume removal
Interventions
usual care with volume removal during continuous renal replacement therapy
blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal
Eligibility Criteria
You may qualify if:
- Patients with kidney injury requiring continuous renal replacement therapy and volume removal
You may not qualify if:
- unable to provide or obtain patient consent
- not expected to survive 48 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dallas VA Medical Center
Dallas, Texas, 75216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of In-center and Home Dialysis
Study Record Dates
First Submitted
July 28, 2011
First Posted
July 29, 2011
Study Start
April 1, 2010
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
August 8, 2012
Record last verified: 2012-08